MIT-MGB Seed Program
The MIT-MGB Seed Program funds collaborative research between MIT and Mass General Brigham to advance innovative technologies in health, medicine, and clinical translation.
Funder: Massachusetts Institute of Technology
Due Dates (Anticipated): June 2027 (Initial proposal submission deadline, projected)
Funding Amounts: Approximately 6 joint projects funded annually; typical award supports 1-year projects with funding split between MIT and Mass General Brigham.
Summary: Supports collaborative MIT–Mass General Brigham research to advance transformative innovations in health and medicine, emphasizing new technologies and clinical translation.
Key Information: Requires joint team with investigators from both MIT and Mass General Brigham.
Description
The MIT-MGB Seed Program is a collaborative initiative between the Massachusetts Institute of Technology (MIT) and Mass General Brigham (MGB), with generous support from Analog Devices Inc. Its mission is to fund innovative joint research projects that leverage MIT’s strengths in science, engineering, and technology and MGB’s clinical and scientific expertise. The program focuses on accelerating transformative advances in health and medicine, particularly through the development and application of new technologies with high translational potential for clinical practice. Strategic focus areas include mental health, neurodegenerative diseases, AI-enabled diagnostics, and digital health.
Projects are evaluated for their collaborative impact and likelihood of delivering real-world healthcare solutions. Awardees also gain access to entrepreneurial workshops and networking opportunities with industry leaders to help translate discoveries into practice.
